Logos Global Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.36M Buy
+550,000
New +$6.49M 0.29% 57

Other funds holding TNXP

Logos Global Management's TNXP Position: Q3 2026 in Review

Logos Global Management opened a new position in Tonix Pharmaceuticals (TNXP) in Q3 2026: 550,000 shares worth $5.36M. The stake represents 0.29% of the portfolio and ranks #57 among its holdings.

86 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.

  • Logos Global Management held 550,000 shares of Tonix Pharmaceuticals worth $5.36M as of Q3 2026.
  • Tonix Pharmaceuticals was a new Logos Global Management position in Q3 2026.
  • Tonix Pharmaceuticals made up 0.29% of Logos Global Management's portfolio in Q3 2026, its #57 holding.
  • 86 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.

Based on Logos Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.